Mitoxantrone (MTX) versus mitomycin C (MMC) in the ablative treatment of Ta, T1 superficial bladder tumors. Phase III, randomized prospective study
Mitoxantrone (MXT) &quot;versus&quot; mitomycin C (MMC) en el tratamiento ablativo de los tumores vesicales superficiales Ta, T1. Estudio prospectivo y al azar, en fase III